BUY Hyundai Motor India — Madhu Bansal
byMadhu BansalHorizon: NA (inferred Swing (≤2wk))11 May 2026via CNBC Awaaz.
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Hyundai Motor India announced its Q4 & FY26 financial results, reporting FY26 revenue of INR 707,633 Mn (up 2.3%) and EBITDA of 12.2%. The company also recommended a dividend of INR 21 per share.
NSE · Press Release·8 May · 4d ago
Hyundai Motor India achieved its highest-ever domestic sales for April, selling 51,902 units, a 17% year-on-year growth.
NSE · Press Release·1 May · 2w ago
Audited Financial Results for the quarter and year ended March 31, 2026 and declaration of final dividend of Rs. 21/- per equity share, subject to approval of shareholders
BSE · Board Meeting·8 May · 4d ago
The company has announced its sales numbers.
BSE · Company Update·1 May · 2w ago
Nothing found in this tip’s window yet.
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Hyundai Motor India
- SELL — Amit Seth22 Oct 2026 · Same day · target ₹1,870 · Expired
- BUY — Ashish Bahety, Profitmart Securities16 Oct 2026 · ~2 weeks · target ₹2,060 · SL hit
- BUY — Siddharth Rai Mangala13 Oct 2026 · Same day · target ₹2,040 · SL hit
- BUY — Prakash Gaba13 Oct 2026 · Same day · target ₹2,020 · SL hit
- BUY — Ashish Bahety, Profitmart Securities13 Oct 2026 · Same day · target ₹2,020 · Expired
More from Madhu Bansal
- BUY Supriya Lifescience29 Sept 2026 · ~2 weeks · target ₹1,078 · SL hit
- BUY Supreme Petrochem29 Sept 2026 · ~2 weeks · target ₹957 · SL hit
- BUY Poonawalla Fincorp18 Sept 2026 · ~2 weeks · target ₹486 · Target hit
- BUY Prudent Corporate Advisory Services18 Sept 2026 · ~3 months · target ₹3,762 · SL hit
- BUY Sun Pharma Advanced Research Company17 Sept 2026 · ~2 weeks · target ₹208 · Target hit

